Back to Search
Start Over
Hyperactivity induced by the dopamine D-2/D-3 receptor agonist quinpirole is attenuated by inhibitors of endocannabinoid degradation in mice
- Source :
- CONICET Digital (CONICET), Consejo Nacional de Investigaciones Científicas y Técnicas, instacron:CONICET, Repositorio Abierto de la UdL, Universitad de Lleida, Recercat. Dipósit de la Recerca de Catalunya, instname
- Publication Year :
- 2013
- Publisher :
- Oxford University Press, 2013.
-
Abstract
- The present study was designed to investigate the effect of pharmacological inhibition of endocannabinoid degradation on behavioural actions of the dopamine D2/D3 receptor agonist quinpirole in male C57Bl/6J mice. In addition, we studied the effects of endocannabinoid degradation inhibition on both cocaine-induced psychomotor activation and behavioural sensitization. We analysed the effects of inhibition of the two main endocannabinoid degradation enzymes: fatty acid amide hydrolase (FAAH), using inhibitor URB597 (1 mg/kg); monoacylglycerol lipase (MAGL), using inhibitor URB602 (10 mg/kg). Administration of quinpirole (1 mg/kg) caused a temporal biphasic response characterized by a first phase of immobility (0–50 min), followed by enhanced locomotion (next 70 min) that was associated with the introduction of stereotyped behaviours (stereotyped jumping and rearing). Pretreatment with both endocannabinoid degradation inhibitors did not affect the hypoactivity actions of quinpirole. However, this pretreatment resulted in a marked decrease in quinpirole-induced locomotion and stereotyped behaviours. Administration of FAAH or MAGL inhibitors did not attenuate the acute effects of cocaine. Furthermore, these inhibitors did not impair the acquisition of cocaine-induced behavioural sensitization or the expression of cocaine-induced conditioned locomotion. Only MAGL inhibition attenuated the expression of an already acquired cocaine-induced behavioural sensitization. These results suggest that pharmacological inhibition of endocannabinoid degradation might exert a negative feedback on D2/D3 receptor-mediated hyperactivity. This finding might be relevant for therapeutic approaches for either psychomotor disorders (dyskinesia, corea) or disorganized behaviours associated with dopamine-mediated hyperactivity. Fil: Luque Rojas, María Jesús. Fundación IMABIS; España Fil: Galeano, Pablo. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Cardiológicas (i); Argentina Fil: Suarez, Juan . Fundación IMABIS; España Fil: Araos, Pedro. Fundación IMABIS; España Fil: Santín Nuñez, Luis Javier. Universidad de Malaga; España Fil: Rodríguez de Fonseca, Fernando. Fundación IMABIS; España Fil: Blanco Calvo, Eduardo. Fundación IMABIS; España. Universidad de Malaga; España
- Subjects :
- Male
CIENCIAS MÉDICAS Y DE LA SALUD
Quinpirole
Endocannabinoid system
Dopamine
Neurociencias
Dopamina
Pharmacology
URB602
chemistry.chemical_compound
Mice
Cocaine
Fatty acid amide hydrolase
Dopamine receptor D2
medicine
Animals
Pharmacology (medical)
Psychomotor Agitation
Receptors, Dopamine D2
Receptors, Dopamine D3
purl.org/becyt/ford/3.1 [https]
URB597
Monoacylglycerol lipase
Mice, Inbred C57BL
Psychiatry and Mental health
Medicina Básica
chemistry
Benzamides
Dopamine Agonists
purl.org/becyt/ford/3 [https]
Carbamates
Stereotyped Behavior
Psychomotor disorder
Stereotyped behaviour
medicine.drug
Endocannabinoids
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- CONICET Digital (CONICET), Consejo Nacional de Investigaciones Científicas y Técnicas, instacron:CONICET, Repositorio Abierto de la UdL, Universitad de Lleida, Recercat. Dipósit de la Recerca de Catalunya, instname
- Accession number :
- edsair.doi.dedup.....c4d65f6174001480259b0c066ebd2789